Gene Query: YES1

Dataset Description Geneva Score
Altering cancer transcriptomes using epigenomic inhibitors 80.59
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 80.59
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 67.14
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 54.92
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 53.47
hTERT promotes cell adhesion and migration independent of telomerase activity 51.81
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 39.43
Cleavage Factor Im as a key regulator of 3’ UTR length 39.05
MYCi975 regulates MYC target genes 37.04
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 36.31
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 36.31
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 34.41
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 32.82
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 32.03
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 31.87
Hijacking of stress response machinery by oncogenes in acute leukaemia 31.87
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 29.46
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 27.17
Sensing self and nonself circular RNAs 27.1
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 26.17
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 26.17
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 25.68
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 25.58
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 24.9
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 24.72
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 23.16
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 22.53
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 22.53
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 22.39
TFAP2C signalling in human fibroblasts 22.38
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 22.05
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 21.7
HNRNPL and its RNA Targets in Prostate Cancer 21.7
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 21.42
The pause-initiation limit restricts transcription activation in human cells 20.75
An RNA-centric dissection of host complexes controlling flavivirus infection 20.71
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 20.71
Analysis of transcriptional regulation by Myt1 and Myt1l 20.07
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 20.05
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 19.81
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 19.77
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 19.68
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 19.51
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 19.51
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 19.27
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 19.01
NRDE2 negatively regulates nuclear exosome functions 18.89
Ribosomal footprinting of CN34-Parental and CN34-LM1a 18.56
Human cell line and subcutaneous tumor 18.54
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 18.23
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 18.19
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 18.11
Nucleoporin-mediated regulation of cell identity genes 17.93
RNA-Seq with and without RNase treatment in PCa cell lines 17.86
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 17.73
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 17.68
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 17.56
RNAseq Analysis in glioblastoma cells treated with Mepazine 17.34
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 17.24
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 17.24
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 17.14
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 17.1
Ribosomal footprinting of MDA-Parental and MDA-LM2 17.07
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 16.68
The cohesin release factor WAPL restricts chromatin loop extension. 16.68
Knockdown of ADNP in HCT116 colon cancer cells 16.38
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 16.26
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 16.26
SLAM-seq for K562 endogenous mRNA decay 16.04
Genes significantly down or Up-regulated upon RNF219 knockdown 15.89
Identifying the molecular mode of action of itraconazole in colorectal cancer 15.88
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 15.79
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 15.79
Identification of Nrf2 regulated genes by RNA sequencing 15.76
Nrf2 regulated genes in A549 cells 15.76
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 15.71
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 15.68
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 15.52
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 15.47
Active translatome profiling with RiboLace in MCF7 cells 15.36
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 15.03
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 14.95
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 14.86
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 14.82
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 14.68
MEIS1 regulates hematopoiesis in hPSCs 14.6
RNA-seq analysis to identify the genes regulated by p53-SET interplay 14.46
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 14.46
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 14.41
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 14.36
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 14.32
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 14.32
Transcriptome analysis of U87 cells upon LINC00152 knockdown 14.32
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 14.09
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 14.09
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 14.0
RNA expression analysis upon JMJD1C depletion 13.98
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 13.98
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 13.94
Gene expression changes upon drug withdrawal (Mel888 cell line) 13.78
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.74
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 13.4
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 13.37
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 13.34
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 13.26
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 13.21
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 13.19
RNA seq_PDX2_SHP099 13.1
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 13.03
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 13.0
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 12.93
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 12.89
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 12.89
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 12.8
Non-coding regions are the main source of tumor-specific antigens [human] 12.8
Non-coding regions are the main source of tumor-specific antigens 12.8
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 12.74
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 12.61
Disruption of the exocyst induces podocyte loss and dysfunction 12.56
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 12.51
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 12.51
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 12.3
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 12.3
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 12.29
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 12.29
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 12.27
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 12.22
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 12.22
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 12.1
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 11.96
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 11.91
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 11.81
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 11.76
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 11.75
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 11.71
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 11.7
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 11.64
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 11.64
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 11.57
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 11.42
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 11.38
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 11.37
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 11.37
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 11.26
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.22
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 11.21
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 11.18
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 11.13
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 11.09
Irf9 function in immunity in mouse 11.02
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 11.02
Conservative alteration of chromosomal expression pattern across human solid tumor types 10.99
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 10.86
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 10.82
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 10.81
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 10.81
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 10.76
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 10.74
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 10.74
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 10.71
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.68
Hepatocyte maturation 10.64
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 10.57
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 10.53
Solid phase chemistry to covalently and reversibly capture thiolated RNA 10.4
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.37
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 10.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 10.32
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 10.27
Regulation of protein translation during mitosis 10.27
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 10.24
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 10.24
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 10.15
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 10.15
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 10.13
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 10.12
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 10.04
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 10.01
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 9.97
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 9.97
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 9.93
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 9.91
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 9.89
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 9.89
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 9.89
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 9.82
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 9.72
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 9.69
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 9.69
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 9.68
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 9.63
Exploring the RNA landscape of endothelial exosomes 9.62
Integrin signaling regulates YAP/TAZ to control skin homeostasis 9.61
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 9.6
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 9.55
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 9.51
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 9.49
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 9.44
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 9.43
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 9.41
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.4
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 9.38
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.33
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.32
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 9.3
Genome-wide discovery of human splicing branchpoints [RNAse] 9.29
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 9.19
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 9.12
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 9.01
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 8.99
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 8.98
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.94
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.94
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 8.93
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 8.93
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 8.93
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 8.9
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.89
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 8.85
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 8.82
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 8.82
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.78
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.78
BASP1 modifies the Tamoxifen response 8.78
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 8.72
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 8.71
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 8.7
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 8.7
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 8.69
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 8.69
RNA-sequencing of human liver tissue 8.69
A role for ZNF598 in post-transcriptional gene regulation 8.65
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 8.64
HBEC-shp53-PCHD7 8.62
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.58
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.58
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.57
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 8.54
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 8.5
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 8.4
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 8.4
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 8.33
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 8.33
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 8.33
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 8.31
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 8.26
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 8.18
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 8.14
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 8.12
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 8.08
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 8.06
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 8.02
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.01
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.01
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 7.97
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 7.88
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 7.87
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 7.87
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 7.85
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.84
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 7.82
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.75
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.72
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 7.67
Transcriptome-wide response to synthetic chromatin protein PcTF 7.62
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 7.56
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 7.55
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 7.55
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.52
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.52
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 7.45
Induced DNA demethylation, genome instability and transcription 7.42
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 7.42
Gene expression profile in breast cancer cells 7.4
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 7.4
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 7.31
FGF2 regulation of gene expression in stable inducible Neurons 7.23
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 7.17
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 7.11
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 7.11
Noncoding regions are the main source of targetable tumor-specific antigens 6.99
Effect of PBK knockdown on C4-2 cell transcriptome 6.97
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.95
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 6.91
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.88
Reassessment of Exosome Composition 6.83
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 6.83
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.7
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 6.63
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 6.57
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 6.57
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.46
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 6.44
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.4
RNA-seq of RKO cells with cTAZ KO or putback 6.32
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 6.25
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 6.25
Transcriptome analysis of BAP1 knockout and restoration 6.24
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 6.24
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 6.19
Transcriptional responses of melanoma cells to BRAF inhibition 6.18
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 6.11
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 6.1
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 6.1
CDK12 mediated transcriptional regulation in U2OS cells 6.08
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 5.98
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 5.97
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 5.88
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 5.87
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 5.84
Transcriptome-wide identification of CELF2 functional targets in T cells 5.79
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 5.7
Role of COP1 on MAP kinase transcriptional output in melanoma 5.7
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 5.7
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.66
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 5.65
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 5.64
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.61
High-throughput sequencing of PROMPT-enriched samples. 5.59
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 5.58
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 5.58
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 5.57
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.49
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 5.43
SOX11 knockdown in B-ALL cell lines 5.42
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 5.38
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 5.36
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.36
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 5.26
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 5.26
Gene Expression Profiling of WT and KDM3A Knocked out Cell 5.25
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 5.25
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 5.23
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 5.23
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.23
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.21
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 5.21
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 5.18
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 5.18
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 5.12
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.1
The transcriptome effect of overexpressing EZH2 in MCF7 4.99
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.9
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.87
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 4.76
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 4.76
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 4.68
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.68
STX4 Over-Expression in Human islets 4.67
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 4.65
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 4.65
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.63
RNA-seq analysis upon ARID1B overexpression 4.59
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 4.57
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.45
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.44
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 4.35
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.31
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.25
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.25
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.17
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 4.16
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 4.11
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 4.08
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.99
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.99
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.97
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 3.96
Oncogenic roles of ARID5B in T-ALL 3.96
Mitochondrial dsRNA triggers antiviral signalling in humans 3.92
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.91
Interaction between mitoNEET and NAF-1 in cancer cells 3.77
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 3.75
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.7
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.7
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.68
The contribution of Alu exons to the human proteome 3.59
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.57
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.56
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 3.52
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 3.52
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.47
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 3.44
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 3.43
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.4
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.4
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.38
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.38
The MEF2B Regulatory Network 3.25
The MEF2B Regulatory Network - RNA-seq data 3.25
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.17
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 3.09
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.04
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.03
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.03
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.0
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.99
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.95
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.88
Regulatory network controlling tumor-promoting inflammation in human cancers 2.88
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.83
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 2.63
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 2.63
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.56
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 2.54
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.5
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.42
A code of mono-phosphorylation modulates the function of RB. 2.42
Identification of global XBP1s target gene expression in human prostate cancer cells 2.42
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.38
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.33
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 2.25
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.15
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 2.13
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 2.13
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.11
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.11
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.03
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.0
Aneuploidy triggers an immune response 1.98
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.9
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 1.9
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 1.88
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.86
mRNA-Seq profiling of human developing kidney 1.85
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.81
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 1.78
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 1.78
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.75
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.73
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.69
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.68
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.68
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 1.67
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.66
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 1.62
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.62
N6-methyladenine DNA Modification in Glioblastoma 1.6
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.6
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.52
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.51
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.49
Copper Regulation of HIF-1 Transcription Activity 1.49
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.44
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.44
Transcriptome of U251 cells overexpression complement component 7 1.41
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.28
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 1.22
RNA splicing alteration on glioblastoma and normal neural stem cells 1.18
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.18
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.17
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.17
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.16
Effects of transcription on genome - nuclear lamina interactions 1.16
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.16
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.11
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.07
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.01
Transcriptomes in healthy and CHB fetal hearts 0.98
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.97
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 0.97
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.96
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.94
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.92
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.88
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.82
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.82
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.77
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 0.77
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.75
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.71
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.7
Transcriptome-wide modulation of splicing by the exon junction complex 0.67
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.66
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.65
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.59
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.58
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.52
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.52
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.52
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.43
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.4
6mer seed toxicity in viral microRNAs 0.39
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.37
Modulation of nonsense-mediated decay by rapamycin 0.36
Iron response of HepG2 cells 0.35
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.34
RNAseq of Breast cancer PDX samples 0.33
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.25
RNA-seq analysis of control and Myc-induced U2OS cells 0.22
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.22
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.21
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.19
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.18
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.15
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.12
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.09
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.02
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.01
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation